Skip to main content

and
  1. Article

    Open Access

    COVID-19 severity scale for claims data research

    To create and validate a methodology to assign a severity level to an episode of COVID-19 for retrospective analysis in claims data.

    Trudy Millard Krause, Raymond Greenberg, Lopita Ghosh in BMC Health Services Research (2023)

  2. Article

    Open Access

    Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains

    Patients with fibromyalgia (FM) report widespread pain, fatigue, and other functional limitations. This study aimed to provide an assessment of the burden of illness associated with FM in France and its associ...

    Serge Perrot, Caroline Schaefer, Tyler Knight in BMC Musculoskeletal Disorders (2012)

  3. Article

    Open Access

    The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States

    Fibromyalgia (FM) is characterized by chronic, widespread pain, fatigue, and other symptoms; yet few studies have comprehensively assessed its humanistic burden. This observational study evaluates the impact o...

    Caroline Schaefer, Arthi Chandran, Meghan Hufstader in Health and Quality of Life Outcomes (2011)

  4. Article

    Open Access

    Valuation of transfusion-free living in MDS: results of health utility interviews with patients

    This study measured how myelodysplastic syndrome (MDS) patients value transfusion independence (TI), reduced transfusions (RT) and transfusion-dependence (TD) using health utility assessment methodology.

    Agota Szende, Caroline Schaefer, Thomas F Goss in Health and Quality of Life Outcomes (2009)

  5. No Access

    Article

    Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration

    There is limited previous research examining the healthcare costs of neovascular age-related macular degeneration (NV-AMD), which constrains our understanding of the economic impact of this condition. With agi...

    Dr Alan F. Cruess, Gergana Zlateva, **ao Xu, Gièle Soubrane in PharmacoEconomics (2008)

  6. No Access

    Article

    A taxonomy of health utility assessment methods and the role for uncertainty analysis

    Agota Szende, Caroline Schaefer in The European Journal of Health Economics (2006)